Short Interest in Awakn Life Sciences Corp. (OTCMKTS:AWKNF) Declines By 84.2%

Awakn Life Sciences Corp. (OTCMKTS:AWKNF) was the target of a large drop in short interest during the month of October. As of October 31st, there was short interest totalling 7,100 shares, a drop of 84.2% from the October 15th total of 44,900 shares. Based on an average daily volume of 14,100 shares, the short-interest ratio is currently 0.5 days.

Awakn Life Sciences Price Performance

AWKNF remained flat at $0.09 during trading on Thursday. The company had a trading volume of 13,950 shares, compared to its average volume of 14,729. The stock has a 50 day simple moving average of $0.08 and a 200 day simple moving average of $0.09. Awakn Life Sciences has a twelve month low of $0.04 and a twelve month high of $0.19.

About Awakn Life Sciences

Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company has a collaboration agreement with the University of Exeter for exploring the use of ketamine-assisted therapy to treat Severe AUD.